Advertisement

Adverse Events

Removing Bias from HEOR: Standardizing the Costs of Adverse Events

C T2023-11-15T13:08:15-05:00June 15th, 2015|Categories: Blog, HEOR Feature|Tags: #AdverseEvents, #RxCost, Adverse Events, budget impact models, Cost Effectiveness Analysis, costings, Costs, Health Economic Models, Health Economics and Outcomes Research, health outcomes models, HEOR, payers, tHEORetically Speaking|

By Jim Davis What are the total costs of prescribing a particular drug? At its core, all health [...]

21st Century Cures and Off-Label Promotion Benefit HEOR and Drug Safety

C T2023-11-15T17:41:29-05:00June 4th, 2015|Categories: Blog, HEOR Feature|Tags: 21st Century Cures, Adverse Events, FDA, FDAMA 114, Health Economic Models, Health informatics, tHEORetically Speaking, transparency|

By Jim Davis As my writing for the AdverseEvents Blog can attest, I’m in favor of data transparency. [...]